Beke; Lijs

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beke; Lijs.The latest application filed is for "use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor".

Company Profile

5.5.8

Beke; Lijs - Antwerp BE
BEKE; Lijs - Freiburg DE
Beke; Lijs - Beerse BE
Beke; Lijs - Heverlee BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of Biomarkers in Identifying Cancer Patients That Will Be Responsive to Treatment With a PRMT5 Inhibitor App 20220205026 - Brehmer; Dirk ; et al.	2022-06-30
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 11,318,157 - Wu , et al. May 3, 2	2022-05-03
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor Grant 11,279,970 - Brehmer , et al. March 22, 2	2022-03-22
Novel Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 Inhibitors App 20210371433 - Wu; Tongfei ; et al.	2021-12-02
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors Grant 11,098,062 - Wu , et al. August 24, 2	2021-08-24
Substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,898,504 - Berthelot , et al. January 26, 2	2021-01-26
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200360416 - Wu; Tongfei ; et al.	2020-11-19
Novel Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200289539 - BERTHELOT; Didier Jean-Claude ; et al.	2020-09-17
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,653,711 - Wu , et al.	2020-05-19
Use Of Biomarkers In Identifying Cancer Patients That Will Be Responsive To Treatment With A Prmt5 Inhibitor App 20200010881 - Brehmer; Dirk ; et al.	2020-01-09
Novel Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As Prmt5 Inhibitors App 20190263833 - WU; Tongfei ; et al.	2019-08-29
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20180243328 - Wu; Tongfei ; et al.	2018-08-30
MSMB-gene based diagnosis, staging and prognosis of prostate cancer App 20090203010 - Beke; Lijs ; et al.	2009-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.